Pyxis Oncology, Inc. (PYXS) Reports In-Line Q1 EPS

Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q1 EPS of ($0.37), in-line with the analyst estimate of ($0.37).

For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Tops Q2 EPS by $6.60, Beats on Revenue
• Maxim Group Starts Heartbeam Inc. (BEAT) at Buy
• Macquarie: Hyatt favored as US hotel revenue growth hits 8.7% in June